Karyopharm Granted Regulatory Designations for Eltanexor for the Treatment of Myelodysplastic Syndromes
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced new...
United States United Kingdom Richard Paulson Selective Inhibitor Of Nuclear Export Karyopharm Therapeutics Inc European Commission
Source: prnewswire.com